Corticosteroids and infliximab impair the performance of interferon-γ release assays used for diagnosis of latent tuberculosis

作者: Alexander Edwards , Yifang Gao , Raymond N Allan , Darran Ball , Hans de Graaf

DOI: 10.1136/THORAXJNL-2016-209397

关键词:

摘要: The impact of immunosuppression on interferon-γ release assays and novel cytokine biomarkers TB infection, mycobacteria-specific IL-2, IP-10 TNF-α responses was investigated in an ex vivo model. Cytokine standard QuantiFERON-TB Gold in-Tube (QFT-GIT) were compared with duplicate containing dexamethasone or infliximab. Dexamethasone converted QFT-GIT results from positive to negative 30% participants. Antigen-stimulated interferon-γ, IL-2 markedly reduced, but preserved. Infliximab caused result conversion up participants substantial reductions all responses. Therefore, corticosteroids anti-TNF-α agents significantly impair assay performance. may be a more robust biomarker than patients receiving corticosteroids.

参考文章(21)
Marc Tebruegge, Binita Dutta, Susan Donath, Nicole Ritz, Benjamin Forbes, Kattia Camacho-Badilla, Vanessa Clifford, Christel Zufferey, Roy Robins-Browne, Willem Hanekom, Stephen M. Graham, Tom Connell, Nigel Curtis, Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis. American Journal of Respiratory and Critical Care Medicine. ,vol. 192, pp. 485- 499 ,(2015) , 10.1164/RCCM.201501-0059OC
Xiaoyu Hu, Wai-Ping Li, Charis Meng, Lionel B. Ivashkiv, Inhibition of IFN-γ Signaling by Glucocorticoids Journal of Immunology. ,vol. 170, pp. 4833- 4839 ,(2003) , 10.4049/JIMMUNOL.170.9.4833
Vanessa Clifford, Christel Zufferey, Susie Germano, Norbert Ryan, David Leslie, Alan Street, Justin Denholm, Marc Tebruegge, Nigel Curtis, None, The impact of anti-tuberculous antibiotics and corticosteroids on cytokine production in QuantiFERON-TB Gold In Tube assays Tuberculosis. ,vol. 95, pp. 343- 349 ,(2015) , 10.1016/J.TUBE.2015.02.039
Susana Casas, Ana Andreu, Xavier Juanola, Xavier Bordas, Fernando Alcaide, Raquel Moure, Luis Anibarro, Eva Cuchí, Maria Esteve, Vera Ortiz, Maria Rosario Guerra, Jesus Rodríguez, Delia Reina, Georgina Salvador, Jordi Guardiola, Xavier Surís, Maria Angeles Pascual, Carmina Martí, Xavier Martínez-Lacasa, Jordi Cuquet, Lucia Gonzalez, Miguel Santin, Diagnosis of tuberculosis infection by tuberculin skin test and a whole-blood interferon-γ release assay in patients considered for anti–tumor necrosis factor-α therapy Diagnostic Microbiology and Infectious Disease. ,vol. 71, pp. 57- 65 ,(2011) , 10.1016/J.DIAGMICROBIO.2010.12.020
R. J. Hewitt, M. Francis, A. Singanayagam, O. M. Kon, Screening tests for tuberculosis before starting biological therapy. BMJ. ,vol. 350, ,(2015) , 10.1136/BMJ.H1060
Marc Tebruegge, Nicole Ritz, Karsten Koetz, Antoni Noguera-Julian, James A. Seddon, Steven B. Welch, Maria Tsolia, Beate Kampmann, Availability and Use of Molecular Microbiological and Immunological Tests for the Diagnosis of Tuberculosis in Europe PLoS ONE. ,vol. 9, pp. e99129- ,(2014) , 10.1371/JOURNAL.PONE.0099129
Adithya Cattamanchi, Rachel Smith, Karen R Steingart, John Z Metcalfe, Anand Date, Courtney Coleman, Barbara J Marston, Laurence Huang, Philip C Hopewell, Madhukar Pai, Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. Journal of Acquired Immune Deficiency Syndromes. ,vol. 56, pp. 230- 238 ,(2011) , 10.1097/QAI.0B013E31820B07AB
Joseph Keane, Sharon Gershon, Robert P. Wise, Elizabeth Mirabile-Levens, John Kasznica, William D. Schwieterman, Jeffrey N. Siegel, M. Miles Braun, Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent The New England Journal of Medicine. ,vol. 345, pp. 1098- 1104 ,(2001) , 10.1056/NEJMOA011110
E. William St.Clair, Carrie L. Wagner, Adedigbo A. Fasanmade, Benjamin Wang, Thomas Schaible, Arthur Kavanaugh, Edward C. Keystone, The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis & Rheumatism. ,vol. 46, pp. 1451- 1459 ,(2002) , 10.1002/ART.10302